Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene G Olinger

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|August 29, 2020
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronavirusesAnna Bruchez, Ky Sha, Joshua Johnson, et al.
Antiviral Research|September 30, 2014
The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virusAura R Garrison, Barbara G Giomarelli, Calli M Lear-Rooney, et al.
The Journal of Infectious Diseases|April 4, 2017
Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based AssaysJulie Dyall, Brit J Hart, Elena Postnikova, et al.
The Journal of Infectious Diseases|February 4, 2011
High-dose mannose-binding lectin therapy for Ebola virus infectionIan C Michelow, Calli Lear, Corinne Scully, et al.
American Journal of Translational Research|December 8, 2009
FGI-104: a broad-spectrum small molecule inhibitor of viral infectionMichael S Kinch, Abdul S Yunus, Calli Lear, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Viruses|February 21, 2019
Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory MiceJames Logue, Walter Vargas Licona, Timothy K Cooper, et al.
The Journal of Infectious Diseases|July 9, 2018
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus DiseaseLisa Evans DeWald, Julie Dyall, Jennifer M Sword, et al.
The Lancet. Infectious Diseases|April 26, 2015
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort studyDanielle V Clark, Hannah Kibuuka, Monica Millard, et al.
Antimicrobial Agents and Chemotherapy|May 21, 2014
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infectionJulie Dyall, Christopher M Coleman, Brit J Hart, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|August 29, 2020
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronavirusesAnna Bruchez, Ky Sha, Joshua Johnson, et al.
Antiviral Research|September 30, 2014
The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virusAura R Garrison, Barbara G Giomarelli, Calli M Lear-Rooney, et al.
The Journal of Infectious Diseases|April 4, 2017
Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based AssaysJulie Dyall, Brit J Hart, Elena Postnikova, et al.
The Journal of Infectious Diseases|February 4, 2011
High-dose mannose-binding lectin therapy for Ebola virus infectionIan C Michelow, Calli Lear, Corinne Scully, et al.
American Journal of Translational Research|December 8, 2009
FGI-104: a broad-spectrum small molecule inhibitor of viral infectionMichael S Kinch, Abdul S Yunus, Calli Lear, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Viruses|February 21, 2019
Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory MiceJames Logue, Walter Vargas Licona, Timothy K Cooper, et al.
The Journal of Infectious Diseases|July 9, 2018
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus DiseaseLisa Evans DeWald, Julie Dyall, Jennifer M Sword, et al.
The Lancet. Infectious Diseases|April 26, 2015
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort studyDanielle V Clark, Hannah Kibuuka, Monica Millard, et al.
Antimicrobial Agents and Chemotherapy|May 21, 2014
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infectionJulie Dyall, Christopher M Coleman, Brit J Hart, et al.
Pageof 8